Sort
53,477 grants matching “addiction”
Attentional control by uncertainty and reward: parietal and frontal mechanisms
$400,000Jacqueline Gottlieb · Columbia University Health Sciences · R01 · FY2012 · MH
PET Imaging and Cocaine Neuropharmacology
$400,000Emory University · R01 · FY2002 · DA
Alpha 5 nAChR is a Risk Factor within the Dopamine System for Nicotine Addiction
$400,000John A. Dani · University Of Pennsylvania · R01 · FY2017 · DA
Building Research Capacity in Global Tobacco Product Regulation Program
$400,000Vinayak Prasad · World Health Organization · U18 · FY2021 · FD
PET Imaging and Cocaine Neuropharmacology
$400,000Emory University · R01 · FY2001 · DA
Research Tested Intervention Programs/National Registry of Evidence-based Program
$400,000National Cancer Institute · Y01 · FY2012 · CA
Attentional control by uncertainty and reward: parietal and frontal mechanisms
$400,000Jacqueline Gottlieb · Columbia University Health Sciences · R01 · FY2016 · MH
Xenon gas inhalation as a novel treatment for opioid withdrawal syndrome
$400,000Ilya Ilin · General Biophysics, Llc · R41 · FY2025 · DA
Opponent control of action selection in the cortico-basal-ganglia-colliculus loop
$400,000Nuo Li · Baylor College Of Medicine · R01 · FY2023 · NS
In vitro receptor and transporter assays for NIDA medications discovery and abuse
$400,000National Institute On Drug Abuse · Y01 · FY2014 · DA
Personalized Health Assessment Related to Medications (Project PHARM)
$400,000Jason Robert Kilmer · University Of Washington · U01 · FY2018 · DA
UCSF/Kaiser-DOR Program for Developing Independent Women's Health Researchers
$400,000Bernard J Guglielmo · University Of California, San Francisco · K12 · FY2014 · HD
Attentional control by uncertainty and reward: parietal and frontal mechanisms
$400,000Jacqueline Gottlieb · Columbia University Health Sciences · R01 · FY2014 · MH
Advancing precision pain medicines to the clinic
$400,000Ana Maria Moreno · Navega Therapeutics, Inc. · SB1 · FY2023 · NS
Disseminating and Implementing MedSMAâT Families in Emergency Departments: A Randomized Control Trial to Assess Effectiveness of an Evidence-Based Gaming Intervention to Reduce Opioid Misuse
$399,999Olufunmilola Abraham · University Of Kentucky · R18 · FY2025 · HS
Policies to Inform Safe and Equitable Opioid Access for Patients with Advanced Cancer Near End of Life
$399,999Lindsay Marie Sabik · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HS
Mechanisms and Functions of Intermittent Synchronization in Neural and Other Living Systems
$399,999Leonid L Rubchinsky · Indiana University · · FY2018 · MPS
Small Molecule CUL4 Inhibitors as Dual Precision Oncology and Immuno-Oncology Drugs
$399,999Scott D Eliasof · Culnexin Therapeutics, Inc. · R41 · FY2021 · CA
Policies to Inform Safe and Equitable Opioid Access for Patients with Advanced Cancer Near End of Life
$399,999Lindsay Marie Sabik · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HS
Modulation of cancer induced immune suppression via inhibition of SCD1
$399,986Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2022 · CA
Hybrid Deterministic-Stochastic Methodology for Simulating Spatial Evolution in Large Populations
$399,976Dominik Wodarz · University Of California-Irvine · · FY2018 · MPS
Cocaine Addiction and the Role of Serotonin in Orbitofrontal Cortex Function
$399,941Carl Lupica · National Institute On Drug Abuse · ZIA · FY2019 · DA
A Stage Ib Randomized Pilot Study of Mentorship for Addiction Problems (MAP)
$399,900Kathlene Tracy · New York University School Of Medicine · R34 · FY2014 · DA
Commercialization of a Behavioral Digital Health Program for Individuals with Chronic Pain
$399,870Jo Masterson · 2morrow, Inc · SB1 · FY2024 · AT
Dopamine Release Regulation by Co-Released Glutamate and GABA
$399,855Margaret E Rice · New York University School Of Medicine · R01 · FY2015 · DA